CHRISTINA CIVIS: Open Payments
NPI 1548016538 · GRANBURY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 61 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $611 · 2025 $1,160
Food & beverage: $1,160
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $223 |
| Novo Nordisk Inc | 12 | $207 |
| ABBVIE INC. | 12 | $175 |
| Exact Sciences Corporation | 7 | $143 |
| Abbott Laboratories | 3 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Eisai Inc. | 1 | $30 |
| Amgen Inc. | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: Ozempic, VRAYLAR, AIRSUPRA, BREZTRI, Cologuard Collection Kit, FREESTYLE LIBRE, JARDIANCE, REXULTI.
Industry payments across TX — which companies pay providers there.
